Skip to search formSkip to main contentSkip to account menu

Immunooncology

The study of cell surface markers on tumor cells which can be recognized by antibodies, and the development of diagnostic reagents or therapeutic… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
2019
2019
  • H. Ungefroren
  • Expert opinion on therapeutic targets
  • 2019
  • Corpus ID: 195328537
ABSTRACT Introduction: Malignant tumors often escape surveillance and eventual destruction by the host immune system through a… 
Review
2019
Review
2019
Bone metastases are common in men with metastatic castrate-resistant prostate cancer (mCRPC), occurring in 30% of patients within… 
Review
2018
Review
2018
Purpose of review The treatment landscape in advanced and metastatic renal cell carcinoma (RCC) is moving from the inhibition of… 
Review
2018
Review
2018
Immunotherapies are set to become part of the therapeutic repertoire for breast cancer in the near future. Active vaccination is… 
Review
2018
Review
2018
Recent advancements in immunooncology have resulted in the generation of novel therapies such as chimeric antigen receptor (CAR… 
Review
2017
Review
2017
  • R. Au
  • Journal of pharmaceutics
  • 2017
  • Corpus ID: 17786102
Immunooncology (IO) is the buzz word today and it has everyone doing IO research. If we look back at the history of cancer… 
2017
2017
Cancer immunotherapy is coming of age, as outstanding results can be achieved in the therapy of cancer with poor prognosis by… 
Review
2016
Review
2016
Although unlike melanoma, breast cancer is not generally viewed as a highly immunogenic cancer, recent studies have described a… 
Review
2016
Review
2016
Interplay among immune activation and cancer pathogenesis provides the framework for a novel subspecialty known as immunooncology…